Jennifer Nam Choi

  • 304 Citations
20102021
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dr. Choi is the Chief of the Division of Oncodermatology at Robert H. Lurie Comprehensive Cancer Center. She specializes in providing skin care for patients undergoing cancer treatment. Her expertise includes knowledge in recognizing and managing side effects from chemotherapy, including rashes, very dry skin, itching, nail and hair changes, cutaneous metastases, radiation dermatitis and other changes due to radiation, infections in immunosuppressed patients, and toxicities that may arise as a result of stem cell or solid organ transplantation, including graft-versus-host disease and advanced skin cancer. She directs the Inpatient Dermatology Consult service for the Cancer Center, as well as the comprehensive skin care and skin cancer surveillance program for high-risk patients and all cancer survivors. She also helps to oversee Northwestern Memorial’s extracorporeal photopheresis unit. Additionally, she is director of clinical research trials investigating the prevention and treatment of cancer therapy-related side effects. She believes strongly in treating patients with attentive care and true compassion. Dr. Choi also specializes in treating patients with skin cancer, including melanoma, squamous cell carcinoma and basal cell carcinoma. She is Co-Leader of the Skin Disease Team and an integral member of the Northwestern Melanoma Unit. For all skin cancer patients, she conducts rigorous screening skin examinations on a regular basis to detect skin cancers and sun damage to optimize prevention and therapy. She is experienced with surgical treatment of skin cancers, as well as non-surgical methods to treat skin cancer and precancerous lesions. Dr. Choi also runs a full medical and surgical dermatology practice. She is experienced with the use of complex dermatologic therapy, including biologic therapy, immunosuppressive medications, and phototherapy. Dr. Choi received her BA degree from Harvard University and her MD degree from Yale University School of Medicine. She completed internship in Internal Medicine at Brigham and Women's Hospital/Harvard Medical School and residency in Dermatology at Yale, where she served as Chief Resident.

Certifications and Licenses

American Board of Dermatology

Training Experience

2002Postdoctoral Fellowship, Yale University
2004Internship, Brigham & Women's Hospital
2007Residency, Yale University

Education/Academic qualification

MD, Yale University

… → 2003

Keywords

  • Cancer Survivorship
  • Chemotherapy
  • Melanoma
  • Skin Cancer

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Melanoma Medicine & Life Sciences
Skin Medicine & Life Sciences
imiquimod Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Skin Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Proto-Oncogene Proteins B-raf Medicine & Life Sciences
Lichenoid Eruptions Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2019

Rare case of leukemia cutis presenting as erythroderma in a patient with acute myeloid leukemia

Donaldson, M., Ebia, M. I., Owen, J. L. & Choi, J. N., Feb 1 2019, In : JAAD Case Reports. 5, 2, p. 121-123 3 p.

Research output: Contribution to journalArticle

Exfoliative Dermatitis
Acute Myeloid Leukemia
Leukemia

Rare presentation of cutaneous lung cancer metastasis presenting as carcinoma erysipeloides

Kwa, M. C., Dulmage, B. O., Shastry, J. L., Yazdan, P. & Choi, J. N., Apr 1 2019, In : JAAD Case Reports. 5, 4, p. 332-335 4 p.

Research output: Contribution to journalArticle

Open Access
Skin Neoplasms
Lung Neoplasms
Neoplasm Metastasis
Carcinoma
1 Citation (Scopus)
Immunotherapy
Melanoma
Neoplasm Metastasis
Skin
3 Citations (Scopus)

Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer

Chu, C. Y., Choi, J. N., Eaby-Sandy, B., Langer, C. J. & Lacouture, M. E., Aug 1 2018, In : Oncologist. 23, 8, p. 891-899 9 p.

Research output: Contribution to journalReview article

Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases
Lung Neoplasms
Paronychia
Pruritus

Vitiligo in a patient undergoing nivolumab treatment for non–small cell lung cancer

Kosche, C., Mohindra, N. A. & Choi, J. N., Nov 1 2018, In : JAAD Case Reports. 4, 10, p. 1042-1044 3 p.

Research output: Contribution to journalArticle

Vitiligo
Non-Small Cell Lung Carcinoma
Immunotherapy
Therapeutics
nivolumab